High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM - Concepedia

Concepedia

Publication | Closed Access

High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM

48

Citations

30

References

2013

Year

Charikleia Kelaïdi, Odile Beyne‐Rauzy, Thorsten Braun, Rosa Sapena, Pierre Cougoul, Lionel Adès, Fabien Pillard, Christine Lambert, J.-C. Charniot, A. Guerci,

Annals of Hematology

Darbepoetin AlfaHematologyHigh Response RateTranslational ResearchPharmacotherapyExercise CapacityMedicine

References

	Year	Citations

Page 1